Beijing's medical insurance drugs are fully integrated into the information bank management will have an irreversible impact on national prices.

On August 12, the Beijing Municipal Medical Insurance Bureau and the Beijing Municipal Medical Insurance Center announced the Notice on issues related to the issuance of the Beijing Basic Medical Insurance Work Injury Insurance and Maternity Insurance Drug Filing (Trial). The
notice specifies in detail the principle of filing, "Where the generic name and dosage form belong to the different specifications, packaging, production enterprises of Western medicine, traditional Chinese medicine (including ethnic medicines) within the scope of the reimbursement of basic medical insurance work injury insurance and maternity insurance drugs in Beijing, the pharmaceutical production or wholesale business enterprises shall file with the Beijing Medical Insurance Administration Center for the record and be incorporated into the management of the drug information bank."
the scope of sunshine procurement in Beijing (including record procurement) or the scope of centralized military procurement, as well as mental, anesthesia, toxicity for medical use, radioactive drugs specially managed by the state are given for the record.
" is the key part of the plan: "To provide false filing information; to raise the purchase price without authorization; and other recorded drugs that seriously violate the regulations of the relevant departments of medical insurance, drug supervision, health, prices, etc., will automatically be disqualified from filing and removed from the drug information base."
" We are used to Fujian Province, Wuhan City and other places in the drug consumption recruitment to play a front wave, although Beijing has long been listed in the drug belt procurement "4 plus 7" and supplies centralized procurement "3 plus 6", in fact, has been very low-key.
this time to put all health insurance drugs into the management of the information base, can be described as a pioneering, responsible reform exploration.
of its coverage and determination to act gave us a presitation that the landscape would change.
Health insurance drugs are all included in the information bank management does not belong to fine management August 14, the State Health Insurance Administration issued the first batch of 3 health insurance management efficiency cases, including "Hebei standardized provincial medical institutions drug procurement behavior" case, Hebei Province Health Insurance Bureau from 11 hospitals in the province to regulate the procurement of 432 drugs, is expected to save more than 90 million yuan a year.
Sefficiely compare the separate practices of Beijing and Hebei Province, we believe that: Hebei Province's health insurance management efficiency cases have been effective in the short term, but long-term adherence to effectiveness, cycle retention efficiency, there are still a lot of variables, need to be further combed to form a long-term mechanism.
Beijing will be all medical insurance drugs into the information bank management, although not yet from the drug control costs, the future is not good statistics, but the starting point on the sealed principles, conducive to long-term implementation.
beijing this practice does not belong to fine management, but must be principle management, this kind of bottom, system design is very important.
the unauthorized increase in the purchase price will be directly removed by the drug information base To clarify one point: Beijing will be all health insurance drugs into the information bank management mentioned in the record, and the record procurement is a complete two things.
Since it is necessary to emphasize specifically not to allow unauthorized increases in procurement prices, that means that the phenomenon before and even at present in the online procurement, record procurement, centralized procurement exists, need to be managed by principle.
We are mainly concerned about three things: First, before and even at present, some pharmaceutical companies arbitrarily subjective price increases, that also can not prevent the hospital to attach to the purchase, the future of pharmaceutical companies have disciplinary measures, hospitals should also strengthen reporting requirements, not reporting, that is, accountability.
, pharmaceutical companies have the right to increase prices, how can it be said that the price increases without authorization? For the hanging network procurement of drugs, when in the purchase and sale contract privately awarded, learning real estate transactions Yin and Yang contract that set, and just happen to have a price gap, then sit on the unauthorized price increase.
the sun must be purchased to ensure sunshine.
third, pharmaceutical companies have the right to increase prices, if the online procurement in the public increase in pricing, or in the record procurement of openly raise pricing, it does not seem to be an unauthorized price increase.
buyers of health insurance in this situation, they either comply with the demands of drug companies to raise prices, or simply delete the drug information bank.
To the 20th option, local health insurance strategy buyers should be proactive and responsive, immediately find local alternatives to similar drugs for price increases, or urgently deploy the same or similar drugs from abroad that have not yet increased prices.
think the feasibility is still very big, after all, any pharmaceutical companies in a place price increase is not difficult, difficult is the national price increase, that is not what is dead.
that the implementation of this system in Beijing has given birth to important changes both locally and throughout the country First, the price of medical insurance drugs in Beijing has a certain impact on the national reference pricing.
and present, some pharmaceutical companies in the actual procurement price is higher, the future will be greatly constrained by this system.
need to explain is that this phenomenon is located at a relatively low level, generally pharmaceutical marketing and hospital one to talk about, is already chaos, should also be blocked.
We are concerned that in the future, after the system came into effect, some pharmaceutical companies deliberately set the price of the Beijing medical insurance drugs they supply higher, and in the hospital procurement at a lower actual price, so that the policy is more harmful."
because it seriously fooled the Beijing medical insurance drug prices as a pricing reference for foreign medical insurance drug procurement platform and competition enterprises.
Preventive measures is to seriously promote the provincial drug centralized procurement of the lowest price linkage mechanism, it is difficult for pharmaceutical enterprises in the country to unify a fixed high price as a breakthrough, in the local special promotion of drug belt procurement, negotiations outside the drug price management, actively explore the mechanism and methods of linking the lowest price at the provincial level, and strive for nothing to be done.
" 'Medicare Drug Catalog' gives the generic name of the drug, and specific to a particular drug may have more than one drug manufacturer can produce, when the drug enters the hospital will use the drug commodity name.
Therefore, before the reimbursement of medical insurance, each pharmaceutical production enterprise needs to file with the relevant departments, and record in detail the general name of the drug, the commodity name, the dosage form, the drug specification adaptive symptoms, the usage amount and the pharmaceutical production enterprise and other information.
" Second, the Beijing Medical Insurance Drug Information Library will reshape the local health insurance drug market.
is the purchase price of drugs, depending on the policy of zero-plus-drug, social supervision of drug prices more convenient.
, such as the price of health insurance drugs, by the hospital procurement link to know, but also by the clinical sales link to know.
2 is in the comparison of drug selection, look forward to the same generic name of different pharmaceutical products in the medical insurance procurement platform, hospital sales terminal on the top of the same generic name and different commodity names, to facilitate the doctor and patients to know, medical insurance information management, drug industry supervision.
Thrance is on the distribution and use of drugs, it is proposed to put forward the access and procurement requirements of medical insurance drugs to all levels of medical insurance fixed-point hospitals, make full use of the access law, exclusion law, to achieve the basic drug supply guarantee of primary health care institutions, as well as the drug economic requirements for the use of special drugs in higher-level hospitals.
this kind of mechanism belongs to the fine management of medical insurance.
.